Hospital management may include intravenous fluids for dehydration, glucose administration for hypoglycaemia, antiemetic medications for nausea and vomiting, and continuous monitoring of blood glucose and vital signs
Average 15% body weight loss over 68 weeks at 2.4 mg (e.g., 30 lbs from 200 lbs starting weight)
Bimagrumab addresses a critical unmet need. Mark Pruzanski The advantage: While people on GLP-1 agonists tend to gain back any weight lost if they stop taking the meds, that might not be the case for bimagrumab 12 weeks after their last dose, the people in the 1,000-person phase 2 trial had yet to regain any weight
As previously described, there is no evidence that bowel toxins pass into blood nor that colon cleansing is required to prevent this [31+]
Polyuria in Adults: A Diagnostic Approach Based on Pathophysiology
Each capsule is precisely dosed and tested for consistency